Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes have?
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes has 2,825 citations in the OpenAlex counts ScholarIQ stores.
When was Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes published?
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes has 2002 year in the ScholarIQ index.
What is the open-access status of Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes?
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes has green oa status in the ScholarIQ index.
What is the DOI of Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes?
The DOI for Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes is on the source record.
What is the PMID of Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes?
The PMID for Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes is on the source record.
What is the OpenAlex record for Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes?
The OpenAlex for Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes is on the source record.